How much revenue did Bionovate Technologies generate this year?
Bionovate Technologies has achieved a revenue of 0 USD this year.
Bionovate Technologies Revenue 2024
Bionovate Technologies Revenue
0 USD
Bionovate Technologies Dividend yield
Ticker
BIIO
ISIN
US09074V2025
In 2024, Bionovate Technologies's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.
The Bionovate Technologies Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | 5.39 | 16,88 |
| 2016 | 6.12 | 16,50 |
| 2015 | 4.44 | 15,54 |
Bionovate Technologies Aktienanalyse
What does Bionovate Technologies do?
Bionovate Technologies Corp is a biotechnology company specializing in the research, development, and marketing of innovative medical devices for the diagnosis and treatment of skin diseases. It was founded in 2017 and is headquartered in Vancouver, Canada. Bionovate Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Bionovate Technologies's Sales Figures
The sales figures of Bionovate Technologies originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Bionovate Technologies’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Bionovate Technologies's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Bionovate Technologies’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Bionovate Technologies Stock
How much was the turnover of the company Bionovate Technologies compared to the previous year?
The revenue of Bionovate Technologies has increased by 0% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Bionovate Technologies?
The revenue of Bionovate Technologies is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Bionovate Technologies measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Bionovate Technologies so important for investors?
The revenue of Bionovate Technologies is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Bionovate Technologies pay?
Over the past 12 months, Bionovate Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionovate Technologies is expected to pay a dividend of 0 USD.
What is the dividend yield of Bionovate Technologies?
The current dividend yield of Bionovate Technologies is .
When does Bionovate Technologies pay dividends?
Bionovate Technologies pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bionovate Technologies?
Bionovate Technologies paid dividends every year for the past 0 years.
What is the dividend of Bionovate Technologies?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bionovate Technologies located?
Bionovate Technologies is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bionovate Technologies kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bionovate Technologies from 6/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/8/2024.
When did Bionovate Technologies pay the last dividend?
The last dividend was paid out on 6/8/2024.
What was the dividend of Bionovate Technologies in the year 2023?
In the year 2023, Bionovate Technologies distributed 0 USD as dividends.
In which currency does Bionovate Technologies pay out the dividend?
The dividends of Bionovate Technologies are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bionovate Technologies
Our stock analysis for Bionovate Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionovate Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Bionovate Technologies Revenue
- Bionovate Technologies Net Income
- Bionovate Technologies P/E
- Bionovate Technologies P/S
- Bionovate Technologies EBIT
- Bionovate Technologies Dividend
- Bionovate Technologies Stocks
- Bionovate Technologies Market capitalization
- Bionovate Technologies Debt
- Bionovate Technologies Liabilities
- Bionovate Technologies Equity
- Bionovate Technologies AAQS
- Bionovate Technologies Employees
- Bionovate Technologies ROE
- Bionovate Technologies ROA
- Bionovate Technologies ROCE
